A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease after allogeneic hematopoietic stem cell transplant.

Ryotaro Nakamura,Corinna La Rosa,Dongyun Yang,Joshua A Hill,Armin Rashidi,Hannah Choe, Qiao Zhou,Chetan Raj Lingaraju,Teodora Kaltcheva,Jeffrey Longmate, Jennifer Drake,Cynthia Slape, Lupe Duarte, Monzr M Al Malki,Vinod A Pullarkat, Ahmed Aribi,Steven Devine,Michael R Verneris, Jeffrey S Miller, Stephen J Forman, Ibrahim Aldoss,Don J Diamond

Haematologica(2024)

引用 0|浏览4
暂无评分
摘要
Not available.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要